Everest Medicines Limited (HKG:1952)
Hong Kong · Delayed Price · Currency is HKD 60.65
+1.50 (2.54%)
Sep 5, 2025, 4:08 PM HKT
Everest Medicines Market Cap
Everest Medicines has a market cap or net worth of 21.44 billion as of September 5, 2025. Its market cap has increased by 243.42% in one year.
Market Cap
21.44B
Enterprise Value
20.51B
Revenue
932.82M
Ranking
n/a
PE Ratio
n/a
Stock Price
60.65
Market Cap Chart
Since October 9, 2020, Everest Medicines's market cap has increased from 20.64B to 21.44B, an increase of 3.89%. That is a compound annual growth rate of 0.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 20.76B | 33.12% |
| Dec 31, 2024 | 15.59B | 132.87% |
| Dec 29, 2023 | 6.70B | 24.60% |
| Dec 30, 2022 | 5.37B | -47.96% |
| Dec 31, 2021 | 10.33B | -47.98% |
| Dec 31, 2020 | 19.85B | -3.81% |
| Oct 9, 2020 | 20.64B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 288.59B |
| Hansoh Pharmaceutical Group Company | 214.91B |
| JD Health International | 206.17B |
| Innovent Biologics | 171.45B |
| Sino Biopharmaceutical | 150.05B |
| WuXi Biologics | 143.61B |
| Akeso | 132.13B |
| CSPC Pharmaceutical Group | 123.82B |